Pharmacie Detroz SRL
1.6 FTEPharmacie Detroz reported total assets of 596,947 € at the end of the 2025 financial year (annual accounts filed with the NBB on 15 Jun 2026), with 1.6 full-time equivalent.
The score of Pharmacie Detroz shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2023 → 2025: Equity +145 % Total assets -5 % Headcount (avg FTE) 0 %
Accounts of the company itself (not consolidated).
The full file covers 3 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Pharmacie Detroz's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 15 Jun 2026
- Year ended 31 Dec 2024filed on 17 Jun 2025
- Year ended 31 Dec 2023filed on 11 Jul 2024
Pharmacie Detroz's financial analysis
- Solvency11.4%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Pharmacie Detroz
Pharmacie Detroz's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0795.517.982
- VAT number
- BE0795517982
- Peppol
- Registered · 0208:0795517982 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 29 Dec 2022
- Registered office
- 1367 Ramillies
- Size
- Micro · 1.6 FTE
- Latest accounts
- 2025 · filed on 15 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Pharmacie Detroz (SRL) has been based in Ramillies since 2022, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 14,006 € and equity of 67,835 €; its revenue is not published. With 1.6 full-time equivalents, it is a micro-enterprise by headcount.
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Pharmacie Detroz
Companies in the same business, of comparable size and area, outside its group.
- Stella and Maynard Retail sale of pharmaceutical products Ghent · balance sheet 597,024 €
- Apotheek HOSTE Retail sale of pharmaceutical products Deinze · balance sheet 596,767 €
- LO-Pharma Retail sale of pharmaceutical products Lubbeek · balance sheet 597,566 €
- Jacky-Mo Retail sale of pharmaceutical products Schaerbeek · balance sheet 597,743 €
- Dubart - Lamalle Retail sale of pharmaceutical products Chaudfontaine · balance sheet 599,335 €
- Etis Pharma Retail sale of pharmaceutical products Pont-à-Celles · balance sheet 599,365 €
- De Bosmolens Retail sale of pharmaceutical products Izegem · balance sheet 599,551 €
- ThePharm Retail sale of pharmaceutical products Antwerp · balance sheet 593,897 €
Frequently asked questions about Pharmacie Detroz
What is the revenue of Pharmacie Detroz?
Pharmacie Detroz files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Pharmacie Detroz?
In Belgium, the VAT number is the company number prefixed with BE: BE0795517982 for Pharmacie Detroz, if the company is VAT-registered. Its company number (CBE) is 0795.517.982.
Where is the registered office of Pharmacie Detroz?
According to the CBE register, the registered office of Pharmacie Detroz is in 1367 Ramillies.
What is the equity of Pharmacie Detroz?
At the close of the 2025 financial year, the equity of Pharmacie Detroz amounts to 67,835 €, a solvency of 11.4% of total assets.
How many people work at Pharmacie Detroz?
1.6 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Pharmacie Detroz?
The register lists 1 active mandates at Pharmacie Detroz. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Pharmacie Detroz
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →